Condition: Alcohol Use Disorder · Alcohol-associated Liver Disease · Sponsor: University of Louisville
To test the efficacy of 6-month LGG compared to placebo in treating Alcoholic Use Disorder (AUD) and liver injury in Alcoholic Hepatitis (AH). And to evaluate the effects of LGG treatment compared to placebo on therapeutic-mechanistic markers of the gut-brain axis and pro-inflammatory activity in patients with AUD and moderate AH
This description comes directly from the study's public registry record.
Amber Jackson, BS CCRP · 502-852-2905 · amber.jackson.1@louisville.edu
Steve Mahanes · 502-852-1388 · steve.mahanes@louisville.edu
Always discuss trial participation with your own doctor first.
| University of Louisville Hospital | Louisville, Kentucky, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05178069